Skip to research content
Back to companies
Episurf Medical AB logo

Episurf Medical AB

Healthcare

Last 12 months

EUR

Net buy/sell balance
€0.00
Public filings
0
Reported buys
€0.00
Reported sales
€0.00
Total reported value
€0.00
Other reported value
€0.00

Activity uses publication dates. This selector changes the chart only; the summary above shows the last 12 months.

Insider trades and share price

Monthly filing activity by publication date and share price, shown for context.

Insider filing data is still loading. Historical price data is still loading.

Loading chart data

Insider activity and price evolution

Signals Pro

Price change after the observation · 1, 3 and 6 months

Net buying
1 month: +0.8%
3 months: +2.9%
6 months: +6.1%
Net selling
1 month: -1.2%
3 months: -2.6%
6 months: -3.8%

Illustrative example with simulated data. These results do not describe this company.

What follows months of insider activity?

Compare monthly net buying and selling with subsequent price movements. Signals Pro quantifies the observed relationship and shows how much evidence supports it.

  • Rank association at the same month and after 1, 3 and 6 months
  • Median price changes after net buying and net selling
  • Sample sizes and evidence levels, without implying causality
Explore Signals Pro

Public filings

Open any row to inspect the regulatory record and its transactions.

All disclosed operations, including compensation and transfers. Values can represent transferred assets rather than cash invested.

DateInsiderRoleTotal reported valueOpen
9 Jun 2023Katarina FlodströmAnnan medlem i bolagets administrations-, lednings- eller kontrollorganDirection unavailable

Not available

Buy/sale net: Not available

Open
9 Jun 2023Sten Fredrik ZetterbergAnnan medlem i bolagets administrations-, lednings- eller kontrollorganDirection unavailable

Not available

Buy/sale net: Not available

Open
8 Jun 2023Pål RyforsVerkställande direktör (VD)Direction unavailable

Not available

Buy/sale net: Not available

Open
8 Jun 2023
Modification
Corrects#A002S895-1
Stephen CaswellAnnan medlem i bolagets administrations-, lednings- eller kontrollorganDirection unavailable

Not available

Buy/sale net: Not available

Open
8 Jun 2023Veronica WallinEkonomichef/finanschef/finansdirektörDirection unavailable

Not available

Buy/sale net: Not available

Open
8 Jun 2023Michael NäsströmAnnan medlem i bolagets administrations-, lednings- eller kontrollorganDirection unavailable

Not available

Buy/sale net: Not available

Open
8 Jun 2023Patrick JamnikAnnan ledande befattningshavareDirection unavailable

Not available

Buy/sale net: Not available

Open
28 May 2023Pål RyforsVerkställande direktör (VD)Direction unavailable

Not available

Buy/sale net: Not available

Open
12 May 2023Laura ShunkStyrelseledamotBuy

US$7,800.00

Buy/sale net: US$7,800.00

Open
8 May 2023Pål RyforsVerkställande direktör (VD)Buy

SEK 661,058.48

Buy/sale net: SEK 661,058.48

Open
22 Feb 2023Leif RydStyrelseledamotBuy

SEK 54,250.00

Buy/sale net: SEK 54,250.00

Open
22 Feb 2023Aktiebolaget Gile MedicinkonsultNot availableBuy

SEK 108,500.00

Buy/sale net: SEK 108,500.00

Open
20 Feb 2023Patrick JamnikAnnan ledande befattningshavareBuy

SEK 52,875.00

Buy/sale net: SEK 52,875.00

Open
20 Feb 2023Pål RyforsVerkställande direktör (VD)Buy

SEK 71,690.50

Buy/sale net: SEK 71,690.50

Open
Direction unavailable

Gross reported

Not available

Evidence
Direction unavailable

Gross reported

Not available

Evidence

Pål Ryfors

8 Jun 2023
Direction unavailable

Gross reported

Not available

Evidence
Direction unavailable

Gross reported

Not available

Evidence

Veronica Wallin

8 Jun 2023
Direction unavailable

Gross reported

Not available

Evidence
Direction unavailable

Gross reported

Not available

Evidence

Patrick Jamnik

8 Jun 2023
Direction unavailable

Gross reported

Not available

Evidence

Pål Ryfors

28 May 2023
Direction unavailable

Gross reported

Not available

Evidence

Laura Shunk

12 May 2023
Buy

Gross reported

US$7,800.00

Evidence

Pål Ryfors

8 May 2023
Buy

Gross reported

SEK 661,058.48

Evidence

Leif Ryd

22 Feb 2023
Buy

Gross reported

SEK 54,250.00

Evidence
Buy

Gross reported

SEK 108,500.00

Evidence

Patrick Jamnik

20 Feb 2023
Buy

Gross reported

SEK 52,875.00

Evidence

Pål Ryfors

20 Feb 2023
Buy

Gross reported

SEK 71,690.50

Evidence

People and insiders

Filings in the last 12 months refer to this company. Luck factor covers the insider’s overall activity; timing uses episodes in this company.

Signals are not available for this disclosure jurisdiction.

InsiderFilings · 12 monthsLuck factorHit rateEpisodesTiming detail
Aktiebolaget Gile MedicinkonsultSource role not reported
0UnavailableUnavailable
Katarina FlodströmAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan
0UnavailableUnavailable
Laura ShunkStyrelseledamot
0UnavailableUnavailable
Leif RydStyrelseledamot
0UnavailableUnavailable
Michael NäsströmAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan
0UnavailableUnavailable
Pål RyforsVerkställande direktör (VD)
0UnavailableUnavailable
Patrick JamnikAnnan ledande befattningshavare
0UnavailableUnavailable
Sten Fredrik ZetterbergAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan
0UnavailableUnavailable
Stephen CaswellAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan
0UnavailableUnavailable
Veronica WallinEkonomichef/finanschef/finansdirektör
0UnavailableUnavailable

Evidence

Open a filing in the activity ledger to inspect its transactions, original regulatory document and source provenance.

Activity